m+Medelevator.RU
← Поиск публикаций
Future oncology (London, England) · 2018

Evaluation of the eighth American Joint Committee on Cancer staging system for malignant melanoma of the skin.

СтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Abdel-Rahman Omar

Аннотация

AIM: To validate the changes among the American Joint Committee on Cancer (AJCC) eighth staging system for cutaneous melanoma.

METHODOLOGY: Surveillance, Epidemiology and End Results database (2004-2014) was queried. Kaplan-Meier survival estimates were evaluated according to both AJCC seventh and eighth systems.

RESULTS: Overall survival was assessed according to the two editions and p-values for overall trend were significant (p < 0.001) for all scenarios. Notably for pathologically staged patients, the mean survival for stage IIC was lower than that for stage IIIA and IIIB. Likewise, among clinically staged patients the mean survival for stage IIC was lower than that for stage III (these findings were identical among both editions).

CONCLUSION: AJCC eighth system holds comparable performance to AJCC seventh system.

Предметные рубрики MeSH

ИП Урсолов Владлен Сергеевич

ИНН 500118482352 · ОГРНИП 314500117700049

Реквизиты и контакты